CTOs on the Move

option one

www.oohme.com

 
option one is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.oohme.com
  • 830 E Parkridge Ave
    Corona, CA USA 92879
  • Phone: 951.273.0190

Executives

Name Title Contact Details

Similar Companies

Carestream Health

Carestream`s products make a difference every day. Carestream Health is a health imaging and information technology solutions company. We provide medical and healthcare IT solutions and X-ray film and digital X-ray products for the non-destructive testing market worldwide. We also provide product, technical, and service support, including remote equipment and software management services. In addition, we own over 600 patents in digital imaging, healthcare IT, film, and imaging chemistry. We became Carestream in 2007 when Onex Corporation purchased Eastman Kodak`s Health Group. Today, we employ approximately 6,000 people who serve a global customer base in over 150 countries. Carestream is headquartered in Rochester, New York, with locations around the world.

Newmark Inc

Newmark is a Cheshire, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trilogy International Inc

Trilogy International Inc is a Palm City, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dormer Laboratories

Dormer Laboratories, Inc. is a Etobicoke, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.